v3.26.1
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
2022 USD Financing Warrants
Pre Funded Warrants
Common Stock
Common Stock
2022 USD Financing Warrants
Common Stock
Pre Funded Warrants
Additional Paid-In Capital
Additional Paid-In Capital
2022 USD Financing Warrants
Additional Paid-In Capital
Pre Funded Warrants
Accumulated OCI
Accumulated Deficit
Balance at Dec. 31, 2024 $ 241,448           $ 639,508     $ 819 $ (398,879)
Balance, Shares at Dec. 31, 2024       75,100,763              
Issuance of common shares under employee share purchase plan ("ESPP") Value 186           186        
Issuance of common shares under employee share purchase plan ("ESPP") share       34,017              
Issuance of common shares upon settlement of restricted share unit ("RSU") awards, Shares       186,708              
Exercise of Warrants   $ 874           $ 874      
Exercise of Warrants, Shares         136,346            
Stock-based compensation expense 3,426           3,426        
Exercise of stock options 237           237        
Exercise of stock options, shares       53,541              
Net loss and comprehensive loss (23,365)                 (17) (23,348)
Balance at Mar. 31, 2025 222,806           644,231     802 (422,227)
Balance, Shares at Mar. 31, 2025       75,511,375              
Balance at Dec. 31, 2025 332,327           913,914     1,085 (582,672)
Balance, Shares at Dec. 31, 2025       98,776,265              
Issuance of common shares under employee share purchase plan ("ESPP") Value 276           276        
Issuance of common shares under employee share purchase plan ("ESPP") share       33,787              
Issuance of common shares upon settlement of restricted share unit ("RSU") awards, Shares       169,306              
Exercise of Warrants   $ 15,313 $ 4         $ 15,313 $ 4    
Exercise of Warrants, Shares         901,800 4,000,000          
Amortization of deferred ATM costs (40)           (40)        
Stock-based compensation expense 7,132           7,132        
Exercise of stock options $ 1,196           1,196        
Exercise of stock options, shares 163,350     163,350              
Net loss and comprehensive loss $ (77,359)                 (261) (77,098)
Balance at Mar. 31, 2026 $ 278,849           $ 937,795     $ 824 $ (659,770)
Balance, Shares at Mar. 31, 2026       104,044,508